Jäger D - Search Results

1

[Importance of anesthesia in multimodal oncologic therapeutical concepts].

Weitz J, Weigand MA, Kienle P, Jäger D, Büchler MW, Martin E. Weitz J, et al. Among authors: jager d. Anaesthesist. 2006 Dec;55(12):1299-306. doi: 10.1007/s00101-006-1091-7. Anaesthesist. 2006. PMID: 16998657 Review. German.

2

Immunomodulatory impact of interferon-alpha in combination with chemoradiation of pancreatic adenocarcinoma (CapRI).

Schmidt J, Patrut EM, Ma J, Jäger D, Knaebel HP, Büchler MW, Märten A. Schmidt J, et al. Among authors: jager d. Cancer Immunol Immunother. 2006 Nov;55(11):1396-405. doi: 10.1007/s00262-006-0140-z. Epub 2006 Feb 17. Cancer Immunol Immunother. 2006. PMID: 16485127 Free PMC article.

3

Major combined electrolyte deficiency during therapy with low-dose cisplatin, 5-fluorouracil and interferon alpha: report on several cases and review of the literature [ISRCTN62866759].

Hoffmann K, Marten A, Lindel K, Fritz S, Jager D, Buchler MW, Schmidt J. Hoffmann K, et al. Among authors: jager d. BMC Cancer. 2006 May 10;6:128. doi: 10.1186/1471-2407-6-128. BMC Cancer. 2006. PMID: 16686958 Free PMC article. Review.

4

[Targeted therapy in the treatment of solid tumors and in hematology-oncology. Advances and disappointments].

Jochims C, Mazitschek U, Jäger D, Goldschmidt H. Jochims C, et al. Among authors: jager d. Internist (Berl). 2006 Jun;47(6):633-41. doi: 10.1007/s00108-006-1626-7. Internist (Berl). 2006. PMID: 16767478 Review. German.

5

Impact of interferon-alpha in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI): first data from the immunomonitoring.

Schmidt J, Jäger D, Hoffmann K, Büchler MW, Märten A. Schmidt J, et al. Among authors: jager d. J Immunother. 2007 Jan;30(1):108-15. doi: 10.1097/01.cji.0000211317.15278.27. J Immunother. 2007. PMID: 17198089 Clinical Trial.

6

[Adjuvant treatment of pancreatic cancer].

Michalski CW, Kleeff J, Jäger D, Friess H, Büchler MW. Michalski CW, et al. Among authors: jager d. Dtsch Med Wochenschr. 2007 Apr 13;132(15):803-7. doi: 10.1055/s-2007-973624. Dtsch Med Wochenschr. 2007. PMID: 17427090 Review. German. No abstract available.

7

Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.

Schmidt J, Welsch T, Jäger D, Mühlradt PF, Büchler MW, Märten A. Schmidt J, et al. Among authors: jager d. Br J Cancer. 2007 Sep 3;97(5):598-604. doi: 10.1038/sj.bjc.6603903. Epub 2007 Jul 31. Br J Cancer. 2007. PMID: 17667928 Free PMC article. Clinical Trial.

8

Interferon-alpha in combination with chemotherapy has potent antiangiogenic properties in an orthotopic mouse model for pancreatic adenocarcinoma.

Zhu Y, Tibensky I, Schmidt J, Hackert T, Ryschich E, Jäger D, Büchler MW, Märten A. Zhu Y, et al. Among authors: jager d. J Immunother. 2008 Jan;31(1):28-33. doi: 10.1097/CJI.0b013e318157c682. J Immunother. 2008. PMID: 18157009

9

The evolving role of catumaxomab in gastric cancer.

Lordick F, Ott K, Weitz J, Jäger D. Lordick F, et al. Among authors: jager d. Expert Opin Biol Ther. 2008 Sep;8(9):1407-15. doi: 10.1517/14712598.8.9.1407. Expert Opin Biol Ther. 2008. PMID: 18694358 Review.

10

The localization and density of immune cells in primary tumors of human metastatic colorectal cancer shows an association with response to chemotherapy.

Halama N, Michel S, Kloor M, Zoernig I, Pommerencke T, von Knebel Doeberitz M, Schirmacher P, Weitz J, Grabe N, Jäger D. Halama N, et al. Among authors: jager d. Cancer Immun. 2009 Feb 19;9:1. Cancer Immun. 2009. PMID: 19226101 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters